Cargando…

Safety and effectiveness of replacement with biosimilar growth hormone in adults with growth hormone deficiency: results from an international, post-marketing surveillance study (PATRO Adults)

PURPOSE: To evaluate safety and effectiveness of biosimilar recombinant human growth hormone (rhGH; Omnitrope®) in adults with growth hormone deficiency (GHD), using data from the PATRO Adults study. METHODS: PATRO Adults was a post-marketing surveillance study conducted in hospitals and specialized...

Descripción completa

Detalles Bibliográficos
Autores principales:	Höybye, Charlotte, Beck-Peccoz, Paolo, Murray, Robert D., Simsek, Suat, Stalla, Günter, Strasburger, Christian J., Urosevic, Dragan, Zouater, Hichem, Johannsson, Gudmundur
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270854/ https://www.ncbi.nlm.nih.gov/pubmed/33742320 http://dx.doi.org/10.1007/s11102-021-01139-2

Ejemplares similares

Malignancy risk in adults with growth hormone deficiency undergoing long-term treatment with biosimilar somatropin (Omnitrope(®)): data from the PATRO Adults study
por: Beck-Peccoz, Paolo, et al.
Publicado: (2020)

SAT-437 The Patro Adults Study of Omnitrope® for the Treatment of Adult Patients with Growth Hormone Deficiency: Latest Safety Outcomes Including Diabetes Risk
por: Beck-Peccoz, Paolo, et al.
Publicado: (2019)

No increased risk of glucose metabolism disorders in adults with growth hormone deficiency undergoing long-term treatment with biosimilar somatropin (Omnitrope®): data from an observational, longitudinal study
por: Beck-Peccoz, Paolo, et al.
Publicado: (2019)

Ten years with biosimilar rhGH in clinical practice in Sweden – experience from the prospective PATRO children and adult studies
por: Lundberg, Elena, et al.
Publicado: (2020)

Long-term safety and efficacy of Omnitrope(®) in adults with growth hormone deficiency: Italian interim analysis of the PATRO Adults study
por: Ferone, D., et al.
Publicado: (2017)

Personalized approach to growth hormone replacement in adults
por: van Bunderen, Christa C., et al.
Publicado: (2019)

Long-term safety and efficacy of Omnitrope®, a somatropin biosimilar, in children requiring growth hormone treatment: Italian interim analysis of the PATRO Children study
por: Iughetti, Lorenzo, et al.
Publicado: (2016)

SUN-255 PATRO Children, a Multi-Center, Non-Interventional Study of the Long-Term Safety and Efficacy of Omnitrope® in Children Requiring Growth Hormone Treatment: Comparing United States (US) and Rest of World (ROW) Data
por: Backeljauw, Philippe, et al.
Publicado: (2019)

Safety and effectiveness of Omnitrope(®) (somatropin) in PATRO Children: a multi-center, post-marketing surveillance study comparison of US and international cohort data
por: Backeljauw, Philippe, et al.
Publicado: (2022)

Long-term Safety of Growth Hormone in Adults With Growth Hormone Deficiency: Overview of 15 809 GH-Treated Patients
por: Johannsson, Gudmundur, et al.
Publicado: (2022)

Current Status of Biosimilar Growth Hormone
por: Saenger, Paul
Publicado: (2009)

Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency
por: Takahashi, Yutaka, et al.
Publicado: (2022)

Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations
por: Christiansen, Jens Sandahl, et al.
Publicado: (2016)

Efficacy and Safety of Biosimilar Growth Hormone in Indian Children
por: Khadilkar, Vaman, et al.
Publicado: (2018)

Growth Hormone Research Society perspective on biomarkers of GH action in children and adults
por: Johannsson, Gudmundur, et al.
Publicado: (2018)

Time for a general approval of growth hormone treatment in adults with Prader–Willi syndrome
por: Höybye, Charlotte, et al.
Publicado: (2021)

Copeptin in Growth Hormone-Treated Patients
por: Sjöström, Anna, et al.
Publicado: (2022)

Multi-centre phase IV trial to investigate the immunogenicity of a new liquid formulation of recombinant human growth hormone in adults with growth hormone deficiency
por: Johannsson, G., et al.
Publicado: (2018)

Ten years of biosimilar recombinant human growth hormone in Europe
por: Saenger, Paul
Publicado: (2017)

SUN-254 A Long-Term, Phase IV Study of Omnitrope®, a Recombinant Human Growth Hormone (rhGH), in Short Children Born Small for Gestational Age (SGA)
por: Schwarz, Hans-Peter, et al.
Publicado: (2019)

Serum soluble urokinase plasminogen activator receptor (suPAR) in adults with growth hormone deficiency
por: Höybye, Charlotte, et al.
Publicado: (2019)

Effects of Growth Hormone Treatment on Sleep-Related Parameters in Adults With Prader-Willi Syndrome
por: Shukur, Hasanain Hamid, et al.
Publicado: (2021)

Adult growth hormone deficiency
por: Gupta, Vishal
Publicado: (2011)

Adult Growth Hormone Deficiency
por: Monson, John P
Publicado: (1998)

Extracellular Water and Blood Pressure in Adults with Growth Hormone (GH) Deficiency: A Genotype-Phenotype Association Study
por: Barbosa, Edna J. L., et al.
Publicado: (2014)

Efficacy of growth hormone therapy in adults with childhood-onset growth hormone deficiency
por: Kim, Ja Hye, et al.
Publicado: (2014)

Treatment with Growth Hormone for Adults with Growth Hormone Deficiency Syndrome: Benefits and Risks
por: Díez, Juan J., et al.
Publicado: (2018)

Investigating the role of cortisol and growth hormone in fatty liver development: fatty liver index in patients with pituitary adenomas
por: Auer, Matthias K., et al.
Publicado: (2016)

SAT-LB074 Efficacy and Safety of Once-weekly Somapacitan in Adult Growth Hormone Deficiency (AGHD) Confirmed in a 53‑week Real 1 Trial Extension
por: Johannsson, Gudmundur, et al.
Publicado: (2019)

Diagnosing Growth Hormone Deficiency in Adults
por: Glynn, Nigel, et al.
Publicado: (2012)

Adult Growth Hormone Deficiency – Benefits, Side Effects, and Risks of Growth Hormone Replacement
por: Reed, Mary L., et al.
Publicado: (2013)

Motivation for and adherence to growth hormone replacement therapy in adults with hypopituitarism: the patients‘ perspective
por: Kreitschmann-Andermahr, Ilonka, et al.
Publicado: (2020)

Safety of growth hormone (GH) treatment in GH deficient children and adults treated for cancer and non-malignant intracranial tumors—a review of research and clinical practice
por: Boguszewski, Margaret C. S., et al.
Publicado: (2021)

Growth Hormone Research Society Workshop Summary: Consensus Guidelines for Recombinant Human Growth Hormone Therapy in Prader-Willi Syndrome
por: Deal, Cheri L., et al.
Publicado: (2013)

A phase 2 trial of long-acting TransCon growth hormone in adult GH deficiency
por: Höybye, Charlotte, et al.
Publicado: (2017)

MOD-4023, a long-acting carboxy-terminal peptide-modified human growth hormone: results of a Phase 2 study in growth hormone-deficient adults
por: Strasburger, Christian J, et al.
Publicado: (2016)

Diagnosis and testing for growth hormone deficiency across the ages: a global view of the accuracy, caveats, and cut-offs for diagnosis
por: Yuen, Kevin C J, et al.
Publicado: (2023)

Adult Growth Hormone Deficiency: Current Concepts
por: FUKUDA, Izumi, et al.
Publicado: (2014)

Growth hormone replacement therapy in adults with growth hormone deficiency; thrice weekly low dose administration.
por: Chung, Y. S., et al.
Publicado: (1994)

Growth hormone effects on cortical bone dimensions in young adults with childhood-onset growth hormone deficiency
por: Hyldstrup, L., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_t5eb5o1sm4vm3gjccpo8oc7ar2